Opioid Antagonist
Pregnancy: B — safe for maternal opioid overdose
Naloxone
Brand names: Narcan, Prenoxad, Nyxoid
Adult dose
Dose: 0.4–0.8mg IV, repeat every 2–3 min
Route: IV / IM / SC / Intranasal
Frequency: Every 2–3 min until adequate ventilation (RR >12/min)
Max: 10mg total — if no response, reconsider opioid aetiology
IN: 1.8mg (Nyxoid nasal spray) or 400mcg/0.1ml via MAD. IM: 400–800mcg. Infusion if long-acting opioid: 2/3 of effective bolus dose per hour.
Paediatric dose
Dose: 0.01 mg/kg
Route: IV / IM / Intranasal
Frequency: Every 2–3 min until adequate ventilation
Max: 0.4mg
Concentration: 0.4 mg/ml
Paediatric weight-based calculator
Clinical pearls
- Duration of naloxone 45–90 min is SHORTER than most opioids. Re-sedation is common with diazepam, methadone, sustained-release opioids — observe minimum 2h after last dose.
- In opioid-dependent patients: titrate to achieve RR >12/min, NOT full consciousness — precipitates severe withdrawal and violent agitation.
- Community take-home naloxone (Prenoxad IM, Nyxoid IN): supply to patients on high-dose opioids and their families.
- Buprenorphine (Subutex, Suboxone) reversal: up to 4mg IV required due to partial agonism and high receptor affinity.
Contraindications
- Hypersensitivity to naloxone
- Caution in opioid-dependent patients — precipitates acute withdrawal (violent agitation)
Side effects
- Acute opioid withdrawal syndrome in dependent patients
- Pulmonary oedema (rare)
- Tachycardia, hypertension
- Agitation, combativeness
- Nausea and vomiting
Interactions
- Opioids: competitive mu-opioid receptor antagonist
- Buprenorphine: partial reversal only — higher doses needed (2–4mg IV)
Monitoring
- Respiratory rate
- SpO₂
- level of consciousness — reassess every 15 min for 2h post-treatment
Reference: BNFc; NICE BNF 84; TOXBASE; NPIS; SIGN Opioid Guidelines. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Morphine Milligram Equivalents (MME) Calculator · Pain / Opioids
- Opioid Conversion / Equianalgesic Guide · Pain Management
- Numeric Rating Scale (NRS) Pain Assessment and Management · Pain Management
- Finnegan Neonatal Abstinence Scoring Tool (FNAST) · Neonatal Abstinence Syndrome
- Modified Finnegan Neonatal Abstinence Score (NAS) · Neonatal
- Withdrawal Assessment Tool (WAT-1) for Paediatric Iatrogenic Withdrawal · Critical Care
Drugs
- MorphineRecommendedAnalgesic
- Tramadol hydrochlorideRecommendedAtypical opioid (μ-agonist + SNRI)
- Methadone hydrochlorideRecommendedLong-acting synthetic opioid
Same class
Pathways
Same specialty
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
- Syncope Assessment · ESC 2018 Syncope Guidelines; NICE NG109